Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18697221 | SYSTEMS FOR INCISING TISSUE | March 2024 | November 2025 | Allow | 20 | 2 | 0 | Yes | No |
| 18501507 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR NEUROMODULATION WITH ENHANCED NERVE TARGETING | November 2023 | December 2025 | Allow | 25 | 4 | 0 | Yes | No |
| 18464840 | CONFIGURING PERIMETER OF BALLOON ELECTRODE AS LOCATION SENSOR | September 2023 | August 2024 | Allow | 11 | 1 | 0 | No | No |
| 18359802 | MINIMALLY INVASIVE DEVICE AND METHOD FOR TIGHTENING SAGGING SKIN BY LINEAR TENSING AND STIMULATION OF COLLAGEN PRODUCTION, WHEREIN THE ANESTHESIA, HEAT, AND ADDITIONAL COLLAGEN INDUCTION OR ANTI-INFLAMMATORY FLUIDS CAN BE APPLIED WITH THE SAME APPARATUS AND IN THE SAME AREA | July 2023 | May 2025 | Abandon | 22 | 2 | 0 | No | No |
| 18069370 | Electrophysiology Device with Electrodes Having Increased Surface Area | December 2022 | March 2024 | Allow | 15 | 2 | 0 | No | No |
| 17952615 | Magnetorheological Elastomer And Magnetorheological Fluid For Clinical Wrap | September 2022 | July 2023 | Allow | 9 | 1 | 0 | No | No |
| 17892509 | PULSE FIELD ABLATION FOR THE TREATMENT OF MIGRAINES | August 2022 | October 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17799328 | BALLOON CATHETER AND BALLOON CATHETER SYSTEM | August 2022 | January 2026 | Abandon | 41 | 2 | 0 | Yes | No |
| 17714622 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR NEUROMODULATION WITH ENHANCED NERVE TARGETING | April 2022 | August 2023 | Allow | 16 | 1 | 0 | No | No |
| 17688783 | CRYOSURGICAL SYSTEM WITH PRESSURE REGULATION | March 2022 | July 2023 | Allow | 16 | 2 | 0 | No | No |
| 17620567 | ABLATION SYSTEM AND NERVE DETECTION DEVICE THEREFOR | December 2021 | January 2026 | Abandon | 49 | 2 | 0 | No | No |
| 17555220 | Irreversible Electroporation Return Electrode and System | December 2021 | September 2025 | Abandon | 45 | 3 | 0 | No | No |
| 17613853 | Conductive Member For Use In Radiofrequency Ablation | November 2021 | March 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17608067 | MAPPING AND ABLATION CATHETER WITH MULTIPLE LOOP SEGMENTS | November 2021 | December 2025 | Allow | 49 | 4 | 0 | Yes | No |
| 17452305 | DEVICES, SYSTEMS, AND METHODS FOR TREATMENT OF HEART FAILURE BY SPLANCHNIC NERVE ABLATION | October 2021 | June 2023 | Allow | 20 | 1 | 0 | No | No |
| 17494648 | CATHETER APPARATUSES FOR MODULATION OF NERVES IN COMMUNICATION WITH THE PULMONARY SYSTEM AND ASSOCIATED SYSTEMS AND METHODS | October 2021 | July 2025 | Abandon | 45 | 2 | 1 | Yes | No |
| 17465202 | THERMAL CUTTING-ASSISTED TISSUE RESECTION DEVICES AND SYSTEMS | September 2021 | February 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17403047 | ACCURATE TISSUE PROXIMITY | August 2021 | August 2025 | Allow | 48 | 4 | 0 | Yes | Yes |
| 17376650 | ARTHROSCOPIC DEVICES AND METHODS | July 2021 | August 2024 | Allow | 37 | 3 | 0 | Yes | No |
| 17354386 | ELECTRODE UNIT AND ENDOSCOPE SYSTEM | June 2021 | September 2025 | Abandon | 50 | 2 | 0 | Yes | No |
| 17312495 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL NEUROMODULATION | June 2021 | May 2024 | Allow | 35 | 2 | 0 | No | No |
| 17235119 | ADAPTIVE ECG TRIGGERING IN AN ABLATION SYSTEM | April 2021 | January 2026 | Abandon | 57 | 3 | 0 | Yes | Yes |
| 17282800 | Cryogenic Applicator | April 2021 | January 2026 | Allow | 58 | 3 | 0 | Yes | No |
| 17213525 | MEDICAL DEVICE | March 2021 | August 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17208329 | SYSTEMS AND METHODS FOR PROSTATE TREATMENT | March 2021 | October 2025 | Allow | 55 | 3 | 0 | Yes | No |
| 17202232 | RADIO FREQUENCY ABLATION CATHETER, RADIO FREQUENCY ABLATION SYSTEM FOR LUNGS, CORRESPONDING CONTROL METHODS AND CONTROL APPARATUSES THEREFOR, AND COMPUTER-READABLE STORAGE MEDIUM | March 2021 | June 2025 | Abandon | 51 | 2 | 0 | No | No |
| 17197384 | ROBOTIC COLPOTOMY SYSTEMS | March 2021 | August 2024 | Abandon | 42 | 2 | 1 | Yes | No |
| 17154686 | MINIMALLY INVASIVE DEVICE AND METHOD FOR TIGHTENING SAGGING SKIN BY LINEAR TENSING AND STIMULATION OF COLLAGEN PRODUCTION, WHEREIN THE ANESTHESIA, HEAT, AND ADDITIONAL COLLAGEN INDUCTION OR ANTI-INFLAMMATORY FLUIDS CAN BE APPLIED WITH THE SAME APPARATUS AND IN THE SAME AREA | January 2021 | August 2025 | Abandon | 55 | 4 | 1 | No | No |
| 17137705 | ENDOSCOPIC ULTRASOUND-GUIDED CELIAC PLEXUS ABLATION AND SENSING DEVICE | December 2020 | June 2025 | Abandon | 53 | 4 | 0 | Yes | No |
| 17051359 | ABLATION LESION ASSESSMENT METHOD AND SYSTEM | October 2020 | August 2025 | Abandon | 57 | 3 | 0 | No | No |
| 17078367 | METHODS OF ENSURING PULSED FIELD ABLATION GENERATOR SYSTEM ELECTRICAL SAFETY | October 2020 | January 2025 | Allow | 51 | 2 | 0 | Yes | No |
| 17034078 | MEDICAL DEVICE | September 2020 | December 2024 | Allow | 50 | 3 | 0 | Yes | No |
| 17006725 | INSTRUMENT FOR PRODUCING TISSUE EFFECTS AT OR NEAR AN ENDOMETRIUM | August 2020 | November 2023 | Abandon | 39 | 4 | 0 | Yes | No |
| 16940802 | CONTROLLING IRREVERSIBLE ELECTROPORATION ABLATION USING A FOCAL CATHETER HAVING CONTACT-FORCE AND TEMPERATURE SENSORS | July 2020 | September 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 16946824 | PATCH ELECTRODE INCLUDING TEMPERATURE SENSING CIRCUIT AND METHODS OF USING SAME | July 2020 | February 2023 | Abandon | 31 | 1 | 0 | Yes | No |
| 16908054 | SURFACE ABLATION DEVICE, SYSTEM AND METHOD | June 2020 | August 2024 | Abandon | 50 | 4 | 0 | No | No |
| 16876284 | MINIMALLY INVASIVE ASSEMBLY FOR LUNG ABLATION | May 2020 | January 2025 | Abandon | 56 | 5 | 0 | No | No |
| 16775572 | IRRIGATION FLUID FOR RESECTION | January 2020 | January 2023 | Allow | 36 | 1 | 0 | No | No |
| 16727264 | THERAPEUTIC TISSUE MODULATION DEVICES AND METHODS | December 2019 | June 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 16704371 | CONTROLLED TEMPERATURE WATER BOTTLE | December 2019 | May 2023 | Abandon | 42 | 1 | 0 | No | No |
| 16696965 | OPHTHALMIC DEVICE FOR TREATING DRY EYE | November 2019 | October 2023 | Abandon | 47 | 2 | 0 | No | No |
| 16692363 | CRYOBALLOON FOR INTRAVASCULAR CATHETER SYSTEM | November 2019 | October 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16688926 | COLD LEG WRAP | November 2019 | March 2023 | Abandon | 40 | 1 | 0 | No | No |
| 16673428 | DISSECTION DEVICE FOR TISSUE | November 2019 | February 2023 | Abandon | 39 | 1 | 1 | No | No |
| 16661171 | MEDICAL DEVICE SYSTEMS AND METHODS FOR ACTIVATING TRANSDUCERS BASED ON DELIVERY SHAFT MEMBER TEMPERATURE | October 2019 | November 2023 | Allow | 49 | 4 | 0 | Yes | No |
| 16605350 | PLASMA IRRADIATION DEVICE, HANDPIECE, AND SURGICAL OPERATION DEVICE | October 2019 | April 2025 | Abandon | 60 | 5 | 1 | No | No |
| 16574375 | METHOD AND APPARATUS FOR FACILITATING REDUCTION IN USER'S FATIGUE | September 2019 | September 2023 | Abandon | 48 | 2 | 0 | No | No |
| 16493646 | GENERATOR FOR THE DELIVERY OF HIGH FREQUENCY ALTERNATING CURRENT TO A MEDICAL INSTRUMENT | September 2019 | February 2024 | Allow | 53 | 3 | 0 | Yes | No |
| 16492888 | ADAPTIVE AND SELF-ADAPTIVE PLASMA CANCER THERAPEUTIC PLATFORM | September 2019 | July 2022 | Allow | 35 | 2 | 0 | Yes | No |
| 16541374 | DYNAMIC ABLATION AND SENSING ACCORDING TO CONTACT OF SEGMENTED ELECTRODES | August 2019 | July 2024 | Allow | 59 | 5 | 0 | No | No |
| 16540777 | HANDHELD DISSECTOR | August 2019 | April 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16477204 | ESTIMATION OF EFFECTIVENESS OF ABLATION ADJACENCY | July 2019 | June 2023 | Allow | 47 | 3 | 0 | No | No |
| 16434939 | ARTHROSCOPIC DEVICES AND METHODS | June 2019 | July 2024 | Allow | 60 | 6 | 0 | No | No |
| 16467426 | METHOD AND SYSTEMS FOR REDUCING TREATMENT VARIABILITY AND INCREASING TREATMENT EFFICACY AND DURABILITY | June 2019 | September 2023 | Allow | 52 | 2 | 0 | No | No |
| 16463324 | RADIO FREQUENCY ABLATION CATHETER AND SYSTEM | May 2019 | January 2024 | Abandon | 55 | 4 | 1 | No | No |
| 16403942 | Assembly For Sequentially Percutaneously Applying An Electrode And An Anesthetic To Tissue | May 2019 | February 2023 | Allow | 45 | 2 | 0 | Yes | No |
| 16347158 | HIGH-FREQUENCY THERMAL THERAPY DEVICE | May 2019 | June 2023 | Abandon | 50 | 3 | 0 | Yes | No |
| 16392733 | CUTTING GUARD WITH RADIOFREQUENCY DISSECTION | April 2019 | January 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16392980 | BIPOLAR FORCEPS FOR HEPATIC TRANSECTION | April 2019 | August 2022 | Abandon | 40 | 2 | 0 | Yes | No |
| 16393263 | MULTIFUNCTIONAL ELECTROSURGICAL INSTRUMENTS WITH DYNAMIC ELECTRODE ASSEMBLIES | April 2019 | March 2025 | Allow | 60 | 8 | 0 | Yes | No |
| 16392054 | SYSTEM AND METHOD FOR MICRO-SIZED COLD ATMOSPHERIC PLASMA TREATMENT | April 2019 | October 2022 | Allow | 42 | 2 | 0 | No | No |
| 16391635 | METHODS AND SYSTEMS FOR ULTRASONIC VESSEL SEALING | April 2019 | September 2022 | Allow | 41 | 3 | 0 | Yes | No |
| 16390311 | ARTHROSCOPIC DEVICES AND METHODS | April 2019 | September 2023 | Allow | 53 | 5 | 1 | Yes | No |
| 16389343 | CRYOSURGICAL SYSTEM WITH PRESSURE REGULATION | April 2019 | October 2021 | Allow | 30 | 1 | 0 | No | No |
| 16389154 | MAGNETORHEOLOGICAL ELASTOMER AND MAGNETORHEOLOGICAL FLUID FOR CLINICAL WRAP | April 2019 | July 2022 | Allow | 39 | 2 | 0 | Yes | No |
| 16387215 | ARTHROSCOPIC DEVICES AND METHODS | April 2019 | January 2023 | Allow | 45 | 4 | 1 | No | No |
| 16385994 | MICROWAVE TISSUE ABLATION PROBE WITH NON-METALLIC INTRODUCER SET | April 2019 | December 2021 | Allow | 32 | 3 | 0 | No | No |
| 16384596 | METHOD FOR INHIBITING AIR BUBBLES ON AN INFLATABLE BALLOON OF AN INTRAVASCULAR BALLOON CATHETER SYSTEM | April 2019 | July 2021 | Abandon | 27 | 0 | 1 | No | No |
| 16340106 | INDUCED CELL MORPHOLOGY ELECTROPORATION | April 2019 | May 2024 | Allow | 60 | 3 | 0 | Yes | No |
| 16337828 | ABLATION CATHETER TIP | March 2019 | October 2021 | Allow | 31 | 1 | 0 | No | No |
| 16365938 | DEVICE WITH LOOP ELECTRODES FOR TREATMENT OF MENORRHAGIA | March 2019 | September 2022 | Allow | 42 | 3 | 0 | No | No |
| 16364835 | MEDICAL DEVICES AND RELATED METHODS | March 2019 | August 2022 | Allow | 41 | 3 | 1 | Yes | No |
| 16363892 | APPARATUS FOR TISSUE ABLATION USING RADIOFREQUENCY ENERGY AND METHOD OF USE | March 2019 | April 2022 | Allow | 37 | 2 | 0 | Yes | No |
| 16294667 | THERAPEUTIC ABLATION OF TISSUE USING IMPEDANCE MODULATED RADIO FREQUENCY | March 2019 | October 2022 | Abandon | 43 | 3 | 0 | Yes | No |
| 16290819 | IRRIGATION CONTROL DURING ABLATION | March 2019 | April 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16277974 | MEDICAL DEVICE AND METHOD FOR THE DENERVATION OF RENAL PERIVASCULAR NERVES | February 2019 | August 2022 | Abandon | 42 | 2 | 0 | No | No |
| 16255579 | MULTIELECTRODE CATHETER | January 2019 | July 2025 | Allow | 60 | 4 | 1 | Yes | Yes |
| 16251807 | ENERGY DELIVERY RETURN PATH DEVICES AND METHODS | January 2019 | March 2023 | Abandon | 50 | 4 | 1 | Yes | No |
| 16318447 | DEVICES, SYSTEMS, AND METHODS FOR TREATMENT OF HEART FAILURE BY SPLANCHNIC NERVE ABLATION | January 2019 | September 2021 | Allow | 31 | 1 | 0 | No | No |
| 16220187 | Introducer for Use with an RF Ablation Probe and Associated RF Ablation Probe Assembly | December 2018 | September 2022 | Abandon | 45 | 2 | 1 | Yes | No |
| 16308757 | SYSTEMS AND METHODS FOR IMPROVED DELIVERY OF EXPANDABLE CATHETER ASSEMBLIES INTO BODY LUMENS | December 2018 | May 2023 | Allow | 53 | 3 | 0 | No | No |
| 16198487 | Configuring Perimeter of Balloon Electrode as Location Sensor | November 2018 | February 2023 | Allow | 50 | 3 | 0 | Yes | No |
| 16196255 | IRRIGATION CONTROL DURING ABLATION | November 2018 | April 2023 | Abandon | 53 | 5 | 0 | No | No |
| 16193610 | Electrophysiology Device with Electrodes Having Increased Surface Area | November 2018 | September 2022 | Allow | 46 | 3 | 0 | No | No |
| 16191000 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR NEUROMODULATION WITH ENHANCED NERVE TARGETING | November 2018 | December 2021 | Allow | 37 | 2 | 0 | Yes | No |
| 16182440 | Attaining Higher Impedances for Large Indifferent Electrodes | November 2018 | April 2022 | Abandon | 41 | 1 | 1 | No | No |
| 16180357 | INDIFFERENT ELECTRODE WITH SELECTABLE AREA | November 2018 | March 2025 | Allow | 60 | 9 | 0 | Yes | No |
| 16170689 | USE OF ELECTROMAGNETIC FIELDS IN IRE DEVICE DELIVERY AND THERAPY MONITORING | October 2018 | May 2023 | Abandon | 55 | 7 | 1 | No | No |
| 16091497 | ELECTROSURGICAL APPARATUS AND METHOD FOR PROMOTING HAEMOSTASIS IN BIOLOGICAL TISSUE | October 2018 | May 2021 | Allow | 31 | 1 | 0 | No | No |
| 16087098 | Circular Microwave Ablation Antenna and System | September 2018 | January 2022 | Allow | 40 | 2 | 0 | Yes | No |
| 16120860 | THERMAL ENERGY TREATMENT DEVICE | September 2018 | July 2021 | Abandon | 34 | 1 | 0 | No | No |
| 16110631 | SELF-HEATING PERSONAL COVERING | August 2018 | July 2021 | Abandon | 35 | 0 | 1 | No | No |
| 16109247 | Zone-Controlled Warming System | August 2018 | April 2023 | Abandon | 56 | 6 | 0 | No | No |
| 16105860 | CAUTERIZING DEVICE AND SYSTEM | August 2018 | March 2022 | Allow | 43 | 3 | 0 | Yes | No |
| 16103793 | Intra-Balloon Deflection Mechanism for Enhanced Balloon Maneuverability | August 2018 | February 2025 | Abandon | 60 | 4 | 0 | No | Yes |
| 16103806 | Heat Transfer During Ablation Procedures | August 2018 | December 2022 | Allow | 52 | 4 | 1 | Yes | No |
| 16060993 | ELECTROSURGICAL SYSTEM FOR GENERATING HIGH-FREQUENCY ALTERNATING CURRENT | June 2018 | February 2024 | Allow | 60 | 6 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LANCASTER, LINDSAY REGAN.
With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner LANCASTER, LINDSAY REGAN works in Art Unit 3794 and has examined 87 patent applications in our dataset. With an allowance rate of 52.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner LANCASTER, LINDSAY REGAN's allowance rate of 52.9% places them in the 14% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LANCASTER, LINDSAY REGAN receive 2.95 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LANCASTER, LINDSAY REGAN is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +28.8% benefit to allowance rate for applications examined by LANCASTER, LINDSAY REGAN. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 22.4% of applications are subsequently allowed. This success rate is in the 28% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 12.7% of cases where such amendments are filed. This entry rate is in the 13% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 40.0% of appeals filed. This is in the 8% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.3% of allowed cases (in the 79% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.